JUST IN: FDA Authorizes Pfizer Antiviral Pill for COVID-19 Home Treatment …Sort of Like Ivermectin

The U.S. Food and Drug Administration issued an emergency use authorization for Pfizer’s antiviral pill for the treatment of mild-to-moderate COVID-19 infection on Wednesday.

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic. This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19,” said  Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research.

Pfizer’s Paxlovid becomes the first US authorized home COVID-19 treatment. The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited, Newsmax reported.

According to its press release, Paxlovid significantly reduced the proportion of people with COVID-19 related hospitalization or death from any cause by 88%.

More from FDA Press Release:

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.

Paxlovid is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in those requiring hospitalization due to severe or critical COVID-19. Paxlovid is not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended. The FDA has approved one vaccine and authorized others to prevent COVID-19 and serious clinical outcomes associated with a COVID-19 infection, including hospitalization and death. The FDA urges the public to get vaccinated and receive a booster if eligible. Learn more about FDA-approved or -authorized COVID-19 vaccines.

Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations. Paxlovid is administered as three tablets (two tablets of nirmatrelvir and one tablet of ritonavir) taken together orally twice daily for five days, for a total of 30 tablets. Paxlovid is not authorized for use for longer than five consecutive days.

Read more here.

An antiviral pill from Merck & Co. also is expected soon to be authorized for COVID-19 treatment.

Aside from the two pills mentioned above, Ivermectin is believed to be a treatment for COVID-19 based on testimonies from professional doctors, nurses, and COVID-19 patients. The Gateway Pundit previously reported that a new international report of 64 studies shows Ivermectin has an 86% success rate as prophylaxis and a 67% success rate in the early treatment of coronavirus.

Two Oklahoma doctors, Dr. John Sutton and Dr. David Jayne also shared their success stories about the use of Ivermectin as a treatment for their patients with COVID-19 in nursing homes.

Highly popular podcast host Joe Rogan said he recovered in 3 days after taking monoclonal antibodies, Ivermectin, Z-pak, prednisone, IV vitamin drip.

Even our contributor Wayne Root, beat the COVID-19 in 48 hours with Ivermectin, just like Joe Rogan.

Uttar Pradesh in India and Indonesia started to see COVID-19 cases fall precipitously after its government granted the Emergency Use Authorization for Ivermectin as the therapeutic drug to cure the Covid-19. You can read more of this story here and here.

 

 

 

Photo of author
Jim Hᴏft is the founder and editor of The Gateway Pundit, one of the top conservative news outlets in America. Jim was awarded the Reed Irvine Accuracy in Media Award in 2013 and is the proud recipient of the Breitbart Award for Excellence in Online Journalism from the Americans for Prosperity Foundation in May 2016.

You can email Jim Hoft here, and read more of Jim Hoft's articles here.

 

Thanks for sharing!